Merafloxacin

CAS No. 91188-00-0

Merafloxacin( CI 934 )

Catalog No. M24952 CAS No. 91188-00-0

Merafloxacin is a fluoroquinolone antibacterial, which was also identified as a 1 PRF inhibitor of SARS-CoV-2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 75 In Stock
5MG 116 In Stock
10MG 188 In Stock
25MG 345 In Stock
50MG 501 In Stock
100MG 724 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Merafloxacin
  • Note
    Research use only, not for human use.
  • Brief Description
    Merafloxacin is a fluoroquinolone antibacterial, which was also identified as a 1 PRF inhibitor of SARS-CoV-2.
  • Description
    Merafloxacin is a fluoroquinolone antibacterial, which was also identified as a 1 PRF inhibitor of SARS-CoV-2.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CI 934
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    SARS-CoV-2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    91188-00-0
  • Formula Weight
    379.4
  • Molecular Formula
    C19H23F2N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:Insoluble;Water:Insoluble
  • SMILES
    CCNCC1CCN(C1)C2=C(C=C3C(=C2F)N(C=C(C3=O)C(=O)O)CC)F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sun Y , Abriola L , Surovtseva Y V , et al. Restriction of SARS-CoV-2 Replication by Targeting Programmed 1 Ribosomal Frameshifting In Vitro[J]. bioRxiv : the preprint server for biology:2020.10.21.349225.
molnova catalog
related products
  • [Asn10,Leu11,D-Trp12...

    (Asn10,Leu11,D-Trp12)-pTH-Related Protein (7-34) amide (human, mouse, rat) is a potent PTH-1R antagonist.

  • RSK Substrate, S6 (2...

    RSK Substrate, S6 (231-239)

  • Glenzocimab

    Glenzocimab (ACT017), a Fab fragment of a humanized anti-GPVI monoclonal antibody, demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model and has been studied in acute ischemic stroke and cerebral thrombosis.